TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $493,908 | +378.1% | 156,300 | 0.0% | 0.01% | +500.0% |
| Q2 2023 | $103,314 | -17.1% | 156,300 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $124,665 | -47.4% | 156,300 | +49.0% | 0.00% | -50.0% |
| Q4 2022 | $237,004 | -12.2% | 104,869 | -25.0% | 0.01% | -14.3% |
| Q3 2022 | $270,000 | +2.7% | 139,869 | +97.5% | 0.01% | +16.7% |
| Q2 2022 | $263,000 | – | 70,809 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |